Abstract
Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of
Original language | English |
---|---|
Pages (from-to) | 555-561 |
Number of pages | 7 |
Journal | Pediatrics |
Volume | 121 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2008 |
Externally published | Yes |
Keywords
- 3-nitrotyrosine
- Bronchopuimonary dysplasia
- Carbonyl
- Nitric oxide
- Premature infant
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health